Schizophrenia Research


Schizophrenia Research Overview

The Schizophrenia Research Group at UNM has been conducting research for more than 12 years. The group, led by Dr. John Lauriello, is well-established and has been on the cutting-edge of brain-imaging research and research in the development of long-acting injectables used to treat psychosis. The research group is comprised of dedicated psychiatrists and clinical staff. Medication and brain imaging trials are often available for both first-episode and chronic patients.

 

What is Schizophrenia?


 Schizophrenia is a mental disorder that affects approximately 1% of the population. Schizophrenia affects men and women equally, but often appears earlier in men, usually in the late teens or early twenties, than in women.

There are certain criteria used to diagnose schizophrenia, but it is important to keep in mind that not everyone with the disorder shares the exact same symptoms or characteristics. Some people with schizophrenia hear voices that others don’t hear or become convinced that others are plotting to harm them. Others may show an absence of certain characteristics that make it hard to function socially and to maintain relationships. Working closely with a physician to help ensure an accurate diagnosis and treatment plan is essential.


This is a time of hope for people with schizophrenia and other related psychotic illnesses. Although the cause of the disease has not yet been determined, current treatments can eliminate many of the symptoms and allow people with schizophrenia to live independent and fulfilling lives.